The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

US-Chi­na ten­sions threat­en to en­snare ad­di­tion­al Chi­nese bio­phar­ma con­trac­tors

Last year
China
Pharma

No­var­tis to make com­mer­cial Carvyk­ti; Re­ci­pharm di­vests sev­en fa­cil­i­ties; Lil­ly’s Zep­bound in short­age 

Last year

Biden’s plan for hos­pi­tals to pay more for drugs in short­age is ‘mis­guid­ed,’ group says

Last year
Pharma

As Mer­ck KGaA grows South Ko­re­an foot­print, it al­so ze­roes in on re­gion­al man­u­fac­tur­ing

Last year

Ad­di­tion­al drug­mak­ers flag risks of work­ing with WuXi amid height­ened US scruti­ny

Last year
R&D
Pharma

Lon­za taps Siegfried leader Wolf­gang Wien­and as new CEO

Last year
People

WuXi AppTec, WuXi Bi­o­log­ics con­tin­ue to build out US pres­ence de­spite po­lit­i­cal ten­sions 

Last year
China

Sanofi's dis­tri­b­u­tion deals; As­traZeneca to sup­ply US and Chi­na in­de­pen­dent­ly; Mer­ck KGaA ex­pands in Chi­na

Last year

Bio­phar­ma man­u­fac­tur­ing ‘tur­bu­lence’ boosts in­quiries for In­dia-based providers, lo­cal CD­MO ex­ecs say

Last year

Hunt­ing for ‘cer­tain­ty and sta­bil­i­ty,’ WuXi Bio spot­lights client re­la­tion­ships

Last year
China

In­sulin users face short­age with two of Eli Lil­ly's in­sulins through the be­gin­ning of April

Last year
Pharma

Brazil aims to man­u­fac­ture its own cell ther­a­pies — at a frac­tion of the cur­rent cost

Last year
Cell/Gene Tx

The US could up­end bio­phar­ma man­u­fac­tur­ing. WuXi ri­vals have an open­ing

Last year
China
In Focus

Lead House spon­sor of WuXi-linked bill to leave Con­gress ear­ly

Last year
People
China

Catal­ent cuts 130 work­ers in In­di­ana; Mer­ck KGaA to build in South Ko­rea; Schott ex­pands US foot­print

Last year

Lon­za swoops in with $1.2B to take over Roche’s bi­o­log­ics site in Cal­i­for­nia

Last year

Sen­a­tors press De­part­ment of De­fense on over­re­liance on for­eign drug man­u­fac­tur­ers

Last year
Pharma
FDA+

No­vo Nordisk bol­sters op­er­a­tions in Chi­na with $556M ex­pan­sion project

Last year
China
Pharma

No­var­tis’ CD­MO arm eyes growth, scope to wel­come com­peti­tors’ clients 

Last year

WuXi AppTec's 2023 sales large­ly re­liant on the US, re­port says

Last year
China

Abeona’s new Form 483 is an­oth­er man­u­fac­tur­ing set­back for its rare skin con­di­tion as­set

Last year

Eu­roAPI halts pro­duc­tion at Ital­ian site as qual­i­ty con­trol is­sues due to ‘po­ten­tial’ mis­con­duct come to light

Last year

BeiGene looks be­yond Chi­na as it se­cures new API source, nears open­ing of US site

Last year
China

An API pro­duc­er’s $250M ex­pan­sion; No­ram­co launch­es US API sup­ply; A pack­ag­ing com­pa­ny’s 47% sales jump

Last year
First page Previous page 14151617181920 Next page Last page
A service from the Financial Times